《中华医学杂志（英文）》投稿须知
Instructions for Authors
ABOUT THE JOURNAL
Chinese Medical Journal (CMJ), established in 1887, is an international, peer-reviewed, open-access general medical journal. CMJ is an official journal of the Chinese Medical Association (CMA) and is the oldest medical periodical in China. CMJ is published semimonthly in English both in print and online issues.The journal reports the advances and progress in current medical sciences and technology. It also serves the objective of international academic exchange. The journal allows free access to its contents and permits authors to self-archive final accepted version of the articles on any OAI-compliant institutional/subject-based repository. The most recent (2017) SCI Impact Factor of CMJ is 1.596.
SCOPE OF THE JOURNAL
The journal will cover clinical and basic studies in field of all medicine, especially general medicine. Articles with clinical interest and implications will be given preference.
THE EDITORIAL PROCESS
A manuscript will be reviewed for possible publication with the understanding that it is being submitted to CMJ alone at that point in time and has not been published anywhere, simultaneously submitted, or already accepted for publication elsewhere. The journal expects that authors would authorize one of them to correspond with CMJ for all matters related to the manuscript. On submission, editors review all submitted manuscripts initially for suitability for formal review. Manuscripts with insufficient originality, serious scientific or technical flaws, or lack of a significant message are rejected before proceeding for formal peer-review. Manuscripts that are unlikely to be of interest to the CMJ readers are also liable to be rejected at this stage itself.
Manuscripts that are found suitable for publication in CMJ are sent to two or more expert reviewers. The journal follows a double-blind review process, wherein the reviewers and authors are unaware of each other’s identity. Every manuscript is also assigned to a member of the editorial team, who based on the comments from the reviewers takes a final decision on the manuscript. The comments and suggestions (acceptance/rejection/amendments in manuscript) received from reviewers are conveyed to the corresponding author. If required, the author is requested to provide a point by point response to reviewers’ comments and submit a revised version of the manuscript. This process is repeated till reviewers and editors are satisfied with the manuscript.
Manuscripts accepted for publication are copy edited for grammar, punctuation, print style, and format. Page proofs are sent to the corresponding author. The corresponding author is expected to return the corrected proofs within seven days. It may not be possible to incorporate corrections received after that period. The whole process of submission of the manuscript to final decision and sending and receiving proofs is completed online. To achieve faster and greater dissemination of knowledge and information, the journal publishes articles online as “Ahead of Print” soon after acceptance.
CLINICAL TRIAL REGISTRY
CMJ requires registration of clinical trials. CMJ would consider publishing clinical trials that have been registered with a clinical trial registry that allows free online access to public. Registration in the following trial registers is acceptable: http://www.chictr.org.cn/; http://www.ctri.in/; http://www.clinicaltrials.gov/; http://www.isrctn.org/; http://www.trialregister.nl/trialreg/index.asp; and http://www.umin.ac.jp/ctr and any registry that is a primary register of the WHO International Clinical Trials Registry Platform (ICTRP; www.who.int/ictrp/network/primary/en/index.html).
DATA SHARING
We encourage authors to include a data sharing statement at the end of every research manuscript when submitting their article, in order to follow the requirement of International Committee of Medical Journal Editors (ICMJE) about data sharing for clinical trials.
Data sharing statements must indicate the following: whether individual deidentified participant data (including data dictionaries) will be shared; what data in particular will be shared; whether additional, related documents will be available (study protocol, statistical analysis plan, etc.); when the data will become available and for how long; by what access criteria data will be shared (including with whom, for what types of analyses, and by what mechanism).
If no such further data are available, please use this wording: "Data sharing: no additional data available."
More information:
The DataCite organization (https://www.datacite.org/) has a growing list of repositories for research data.
http://www.icmje.org/news-and-editorials/data_sharing_june_2017.pdf
AUTHORSHIP CRITERIA
As stated in the ICMJE Recommendations, credit for authorship requires:
Substantial contributions to the conception and design, or the acquisition, analysis, or interpretation of the data;
The drafting of the article or critical revision for important intellectual content;
Final approval of the version to be published;
Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the article are appropriately investigated and resolved.
Authorship credit should be based only on substantial contributions to each of the four components mentioned above.
Participation solely in the acquisition of funding or the collection of data does not justify authorship. General supervision of the research group is not sufficient for authorship. Each contributor should have participated sufficiently in the work to take public responsibility for appropriate portions of the content of the manuscript. The order of naming the contributors should be based on the relative contribution of the contributor towards the study and writing the manuscript. Once submitted the order cannot be changed without written consent of all the contributors. Manuscripts must be submitted by one of the authors of the manuscript, and should not be submitted by anyone on their behalf. The corresponding author takes responsibility for the article during submission and peer review.
Changes in authorship
Authors should determine the order of authorship among themselves and should settle any disagreements before submitting their manuscript. Changes in authorship (i.e., order, addition, and deletion of authors) should be discussed and approved by all authors. Any requests for such changes in authorship after initial manuscript submission and before publication should be explained in writing to the editor in a letter or email from all authors and should send the original signed written consent of all authors with authorized unit stamp.
CONFLICTS OF INTEREST/COMPETING INTERESTS
All authors must disclose any and all conflicts of interest, they may have with publication of the manuscript or an institution or product that is mentioned in the manuscript and/or is important to the outcome of the study presented. Authors should also disclose conflicts of interest with products that compete with those mentioned in their manuscript. A conflict of interest may exist when an author (or the author’s institution or employer) has financial or personal relationships or affiliations that could influence (or bias) the author’s decisions, work, or manuscript.
RETRACTION POLICY
CMJ should consider retracting a publication if:
Editors have clear evidence that the findings are unreliable, either as a result of misconduct (e.g., data fabrication) or honest error (e.g., miscalculation or experimental error).
The findings have previously been published elsewhere without proper crossreferencing, permission or justification (i.e., cases of redundant publication).
It constitutes plagiarism.
It reports unethical research.
CMJ abides by Retraction Guidelines of the Committee on Publication Ethics (COPE) (http://publicationethics.org/files/retraction%20guidelines_0.pdf).
SUBMISSION OF MANUSCRIPTS
All manuscripts must be submitted online through the website: www.editorialmanager.com/cmj. First-time users will have to register at this site. Registration is free but mandatory. Registered authors can keep track of their articles after logging into the site using their username and password. Authors do not have to pay for submission of articles. If you experience any problems, please contact the editorial office by E-mail: cmj@cma.org.cn.
The submitted manuscripts that are not as per the “Instructions for Authors” would be returned to the authors for technical correction before they undergo editorial/peer-review. Generally, the manuscript should be submitted in the form of several separate files(the website has a limit of 100 MB per uploaded file):
Title page/First page file/Cover letter:
This file should provide:
The type of manuscript (original article, review article, meta analysis, correspondence, etc.). Title of the manuscript, names of all authors/contributors and name(s) of department(s) and/or institution(s) to which the work should be credited. All information which can reveal your identity should be here. Use text/rtf/doc files. Do not zip the files.
The total number of pages, total number of photographs and word counts separately for abstract and for the text (excluding the references, tables and abstract).
Source(s) of support in the form of grants, equipment, drugs, or all of these.
Acknowledgment, if any. One or more statements should specify: (1) contributions that need acknowledging but do not justify authorship, such as general support by a departmental chair; (2) acknowledgments of technical help; and (3) acknowledgments of financial and material support, which should specify the nature of the support. This should be included in the title page of the manuscript and not in the main article file.
If the manuscript was presented as part at a meeting, the organization, place, and exact date on which it was read. A full statement to the editor about all submissions and previous reports that might be regarded as redundant publication of the same or very similar work. Any such work should be referred to specifically, and referenced in the new paper. Copies of such material should be included with the submitted paper, to help the editor decide how to handle the matter.
Registration number in case of a clinical trial and where it is registered (name of the registry and its uniform resource locator [URL]).
Conflicts of Interest of each author/contributor. A statement of financial or other relationships that might lead to a conflict of interest, if that information is not included in the manuscript itself or in an authors’ form.
A statement that the manuscript has been read and approved by all the authors, that the requirements for authorship as stated earlier in this document have been met, and that each author believes that the manuscript represents honest work, if that information is not provided in another form.
The name, address, E-mail, and telephone number of the corresponding author, who is responsible for communicating with the other authors about revisions and final approval of the proofs.
Author contributions. Contributors should provide a description of contributions made by each of them towards the manuscript. Description should be divided into following categories, as applicable: concept, design, definition of intellectual content, literature search, clinical studies, experimental studies, data acquisition, data analysis, statistical analysis, manuscript preparation, manuscript editing, and manuscript review. One author should take responsibility for the integrity of the work as a whole from inception to published article and should be designated as “corresponding author”.
Blinded article file
The main text of the article, beginning from Abstract till References (including tables) should be in this file. The file must not contain any mention of the authors’ names or initials or the institution at which the study was done or acknowledgments. Page headers/running title can include the title but not the authors’ names. Manuscripts not in compliance with the Journal’s blinding policy will be returned to the corresponding author. Use rtf/doc files. Do not zip the files. Do not incorporate images in the file. The pages should be numbered consecutively, beginning with the first page of the blinded article file.
Images
Submit good quality color images.Size of the image can be reduced by decreasing the actual height and width of the images (keep up to 1600 × 1200 pixels or 5–6 inches). Images can be submitted as JPEG files and should be supplied at an effective resolution of 300 pixels per inch (PPI). Do not zip the files. Legends for the figures/images should be included at the end of the article file.
The copyright transfer form
The copyright transfer form has to be submitted in original with the signatures of all the contributors as a scanned image via CMJ online manuscript submission and review system: http://edmgr.ovid.com/cmj/accounts/CMJ_Copyright_form_FINAL_updated.pdf.
PREPARATION OF MANUSCRIPTS
Manuscripts must be prepared in accordance with “ICMJE Recommendations”. The uniform requirements and specific requirement of CMJ are summarized below. Before submitting a manuscript, contributors are requested to check for the latest instructions available. Instructions are also available from the website of the journal (www.cmj.org) and from the manuscript submission site: www.editorialmanager.com/cmj.
COPIES OF ANY PERMISSION(S)
It is the responsibility of authors/contributors to obtain permissions for reproducing any copyrighted material. A copy of the permission obtained must accompany the manuscript. Copies of any and all published articles or other manuscripts in preparation or submitted elsewhere that are related to the manuscript must also accompany the manuscript.
TYPES OF MANUSCRIPTS
Editorial
Editorials are usually commissioned, however, unsolicited editorials are also welcome. We are keen to consider editorials or ideas for editorials from authors outside China. Editorials can be up to 2000 words length with no more than 25 references.
Original Article
These include randomized controlled trials, basic medical studies, studies of screening and diagnostic test, outcome studies, cost effectiveness analyses, case-control series, and in vitro study.
The text of original articles amounting to about 5000 words (excluding abstract, references and tables) should be divided into sections with the headings Abstract, Key words, Introduction, Methods, Results, Discussion, References, Tables and Figure legends.
Abstract
The abstract of original articles in CMJ is a structured abstract, which includes the following four parts: Background, methods, results, and conclusions. The total number of words in abstract is no more than 300 words.
Introduction
State the purpose and summarize the rationale for the study or observation.
Methods
It should include and describe the following aspects:
Ethics
When reporting studies on human beings, author should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional or regional) and with the Helsinki Declaration of 1975, as revised in 2000 (available at http://www.wma.net/e/policy/17-c_e.html). For prospective studies involving human participants, authors are expected to mention about approval of regional/national/institutional or independent ethics committee or review board, obtaining informed consent from adult research participants and obtaining assent for children aged over 7 years participating in the trial. The age beyond which assent would be required could vary as per regional and/or national guidelines. Ensure confidentiality of subjects by desisting from mentioning participants’ names, initials or hospital numbers, especially in illustrative material. When reporting experiments on animals, indicate whether the institution’s or a national research council’s guide for, or any national law on the care and use of laboratory animals was followed.
Evidence for approval by a local ethics committee (for both human as well as animal studies) must be supplied by the authors on demand. Animal experimental procedures should be as humane as possible and the details of anesthetics and analgesics used should be clearly stated. The ethical standards of experiments must be in accordance with the guidelines provided by the CPCSEA and World Medical Association Declaration of Helsinki on Ethical Principles for Medical Research Involving Humans for studies involving experimental animals and human beings, respectively. The journal will not consider any paper which is ethically unacceptable. A statement on ethics committee permission and ethical practices must be included in all research articles under the “Methods” section.
Study design
Selection and description of participants
Describe your selection of the observational or experimental participants (patients or laboratory animals, including controls) clearly, including eligibility and exclusion criteria and a description of the source population.
Technical information
Identify the methods, apparatus (give the manufacturer’s name and address in parentheses), and procedures in sufficient detail to allow other workers to reproduce the results.
Give references to established methods, including statistical methods (see below); provide references and brief descriptions for methods that have been published but are not well known; describe new or substantially modified methods, give reasons for using them, and evaluate their limitations. Identify precisely all drugs and chemicals used, including generic name(s), dose(s), and route(s) of administration.
Reports of randomized clinical trials should present information on all major study elements, including the protocol, assignment of interventions (methods of randomization, concealment of allocation to treatment groups), and the method of masking (blinding), based on the CONSORT Statement (http://www.consort-statement.org).
更多详情：
http://edmgr.ovid.com/cmj/accounts/ifauth.htm
